Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Registry on Treatment Reality and Sequential Treatments of Patients with Resectable or Locally Advanced/metastatic Pancreatic Cancer in Real-life Practice in Germany

NCT02089269 is registered in ClinicalTrials.gov with iOMEDICO AG as lead sponsor.

NCT NCT02089269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02089269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Registry on Treatment Reality and Sequential Treatments of Patients with Resectable or Locally Advanced/metastatic Pancreatic Cancer in Real-life Practice in Germany
Lead sponsor
iOMEDICO AG
Phase
Observational
Overall status
Completed
Start date
December 31, 2013
Completion date
June 30, 2024
Enrollment
2,325 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas cancer